Jane Lapon possesses extensive experience in market access and strategic leadership within the biotech and pharmaceutical industries. Currently serving as a Board Member at Atorvia and a Board Observer at Gene Bio Medical, Jane has also held the position of Head of Global Market Access at Photocure since June 2021. Previous roles include significant leadership positions at Adherium, Boston Scientific, and BTG plc, focusing on securing reimbursement strategies across various global markets. Jane's background includes deep expertise in oncology and a commitment to addressing high-priority public health challenges, enhanced by a BSc in Pharmacy from the University of Strathclyde.
Links